1996
DOI: 10.1159/000237316
|View full text |Cite
|
Sign up to set email alerts
|

Concentrations of Myeloperoxidase in Nasal Secretions of Atopic Patients after Nasal Allergen Challenge and during Natural Allergen Exposure

Abstract: A quantitativ determination of myeloperoxidase (MPO) concentration was performed in the nasal secretions of atopic patients (challenged group, n = 17) after nasal allergen challenge outside the pollen season, and of patients with ongoing seasonal (seasonal group, n = 40) and with perennial (perennial group, n =30) allergic rhinitis. The concentrations of MPO obtained from 10 nonallergic healthy volunteers (control group) were used as a normal control. Results showed that there was no statistical difference bet… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

1998
1998
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(6 citation statements)
references
References 19 publications
0
6
0
Order By: Relevance
“…Recently, Wang et al [37] used a microsuction technique to measure the concentration of MPO in nasal secretions. Using this technique, the authors were not able to demonstrate any LP increase in MPO levels following nasal allergen challenge of allergic patients.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Wang et al [37] used a microsuction technique to measure the concentration of MPO in nasal secretions. Using this technique, the authors were not able to demonstrate any LP increase in MPO levels following nasal allergen challenge of allergic patients.…”
Section: Discussionmentioning
confidence: 99%
“…In the clinical setting, it is often used to diagnose nasal obstruction and to follow patients treated with medical and surgical procedures to improve nasal patency [9, 10]. Moreover, it can be useful for observing seasonal allergic rhinitis [11], studying nasal hyperresponsiveness [12–14], evaluating various intranasal treatments [15, 16], and for the follow-up of nasal provocation testing with allergic response mediators [17, 18]. The measurement of unilateral nasal resistance also detects anatomical obstructions and helps evaluate the efficacy of corrective surgery.…”
Section: Introductionmentioning
confidence: 99%
“…Primary outcomes were levels of interleukin-5 (IL-5), IL-8, eosinophil cationic protein (ECP), myeloperoxidase (MPO) and cell differentials obtained during the phase of the late allergic reaction (4–24 h). Early protein leakage (α 2 -macroglobulin, A2M) and histamine levels were monitored as an indicator for early mast cell degranulation in the nose [12, 13, 14, 15]. The study was designed to detect a 25% difference in late skin reactivity and a 30% difference in log-normalized levels of soluble markers with a power of 0.80 and a 95% confidence level.…”
Section: Introductionmentioning
confidence: 99%